From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches ...

Two sustained-release procedural pharmaceuticals or drug-delivery options are available in the US: the bimatoprost ...

A new population-based study published in the journal of Advances in Therapy revealed that individuals diagnosed with ...

Through 24 months, scleral bio-reinforced cyclodialysis combined with cataract surgery lowered IOP by enhancing uveoscleral ...

This growth was powered by sales of its foundational glaucoma products.

The vision of a content creator from Minnesota has been gradually deteriorating since she was 6 years old. At 27, she's learning to live differently and independently.

A Eureka eye center that treats hundreds of patients a week is set to close in February, sparking concern over an upcoming shrinkage of doctors who perform specialist eye treatments and surgeries ...

Q. I stopped glucosamine when I found that it can increase eye pressure in glaucoma. My cholesterol on my next checkup a year later was 150. I always was around 210 before then. Now I wonder if the ...

Experts say declining estrogen during menopause is one of the biggest culprits behind "ghost" brows — but new serums offer ...

U.S. Glaucoma net sales reached $80.8 million, with iDose TR contributing approximately $40 million. International Glaucoma net sales were $29.4 million, and Corneal Health franchise net sales totaled ...

VUNO, Kakao Healthcare, Skylabs, and Remidio advance into Europe with partnership deals and regulatory approvals for AI in ...

Nova Eye Medical Ltd (($ELXMF)) announced an update on their ongoing clinical study. Study Overview: The study titled ‘Multicenter Glaucoma Study ...